NexImmune, Inc. Annual Operating Income (Loss) in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
NexImmune, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2020 to 2023.
  • NexImmune, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$3.51M, a 54.9% increase year-over-year.
  • NexImmune, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$21.6M, a 56.5% increase year-over-year.
  • NexImmune, Inc. annual Operating Income (Loss) for 2023 was -$33M, a 47.7% increase from 2022.
  • NexImmune, Inc. annual Operating Income (Loss) for 2022 was -$63.1M, a 18.5% decline from 2021.
  • NexImmune, Inc. annual Operating Income (Loss) for 2021 was -$53.3M, a 91.2% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$33M +$30.1M +47.7% Jan 1, 2023 Dec 31, 2023 10-K 2024-04-16
2022 -$63.1M -$9.83M -18.5% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-16
2021 -$53.3M -$25.4M -91.2% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-28
2020 -$27.9M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.